Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lithocholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel hyodesoxycholic acid route ensures safety and yield. Ideal for pharmaceutical intermediates manufacturing cost reduction and supply chain reliability.
Novel synthetic route for lithocholic acid using hyodesoxycholic acid ensures higher yield and safety. Ideal for pharmaceutical intermediate suppliers seeking cost-effective scalable production solutions.
Patent CN116836214B details a plant-based synthesis route for 7-ketolithocholic acid intermediates, offering high purity and supply chain security for pharmaceutical manufacturing.
Novel two-step synthesis of lithocholic acid from hyodesoxycholic acid offers high yield and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN112899191B reveals a green route from phytosterol to bile acids, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN1912192B reveals a green electrochemical route for 7-keto lithocholic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel chenodeoxycholic acid route offers high purity lithocholic acid. Safe reagents and scalable process reduce manufacturing costs for pharmaceutical supply chains.
Novel esterification-crystallization method removes double oxide impurities, ensuring superior quality for ursodeoxycholic acid production.
Patent CN106977572A reveals a novel two-step synthesis route for lithocholic acid offering high purity and significant supply chain cost reduction advantages.
Patent CN104804055A details silylation purification for 7-ketolithocholic acid ensuring high purity UDCA intermediates and supply chain reliability for global pharmaceutical manufacturers.
Patent CN102660755B reveals electroreduction method for UDCA. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107200763B reveals a novel two-step synthesis for lithocholic acid. This method offers high purity and scalable production for pharmaceutical supply chains.
Patent CN115716857B details a novel aqueous purification route for lithocholic acid achieving over 99 percent purity. This method significantly reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN110423261B reveals a novel synthesis route for 7-ketolithocholic acid from hyocholic acid, offering high purity and significant cost reduction in bile acid manufacturing.